Premium
How quality influences the clinical outcome of external beam radiotherapy for localized prostate cancer
Author(s) -
Van Vulpen Marco,
Van Der Heide Uulke A.,
Van Moorselaar Jeroen R.J.A.
Publication year - 2008
Publication title -
bju international
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.773
H-Index - 148
eISSN - 1464-410X
pISSN - 1464-4096
DOI - 10.1111/j.1464-410x.2007.07346.x
Subject(s) - external beam radiotherapy , prostate cancer , radiation therapy , medicine , external beam radiation , prostate , magnetic resonance imaging , medical physics , radiology , cancer , brachytherapy
For the delivery of good‐quality external beam radiotherapy (EBRT) in localized prostate cancer, under‐dosage to the peripheral zone (tumour) is one likely cause of poor results. The quality is improved by daily verification of the position of the prostate, and the use of magnetic resonance imaging (MRI) in delineation. Currently these are demands on quality that should be incorporated in each radiotherapy department. The use of MRI in staging is also expected to improve patient selection for EBRT. Furthermore, an adequate radiation dose should be delivered. In this overview we describe what the urologist should expect from radiation oncologists to obtain the optimum results for the patients.